Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
{ "CalmiGo Device for Vascular Health After Heart Attack", "This study is looking at whether using the CalmiGo stress management device can improve blood vessel health in people who have recently had a heart attack (myocardial infarction). The CalmiGo device is a small, inhaler-sized tool that uses guided breathing to help you relax. Researchers want to see if using CalmiGo for 12 weeks, along with your usual care, makes a difference compared to just receiving usual care. They will measure changes in your peripheral endothelial function (how well your blood vessels work) to see if the device is helpful. You might be able to join if you are 18 or older, have recently had a heart attack, and are starting cardiac rehabilitation. The current recruitment status is unclear.", "design": "This study plans to enroll 100 participants. Participants will be randomly assigned to either use the CalmiGo device plus standard care, or standard care alone.", "commitments": "You would use the CalmiGo device once a day for 12 weeks if assigned to that group. You will also have blood tests, mental stress testing, physical assessments, and surveys at the beginning and end of the study.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be reassessed after 12 weeks of treatment.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Valentina Nardi, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Peripheral endothelial function16 weeks
Measurements made at baseline will be significantly different between those randomized to CalmioGo + standard of care to those receiving only standard of care treatment